dose reductions of these medications may be needed when initiating GLP-1 therapy
If you're uncertain about technique, PlexusDx provides detailed guidance
While industry proponents frame these as separate and new inventions (or innovations), all three rely on the exact same active ingredient, semaglutide
The FDA is also monitoring the availability of other GLP-1 medications, including dulaglutide and liraglutide, which remain in shortage
However, there are alternative medications to treat diabetes, such as insulin, Metformin, sulfonylureas, dipeptidyl peptidase-4 (DPP-4) inhibitors, sodium-glucose co-transporter 2 (SGLT2) inhibitors, meglitinides, thiazolidinediones and alpha-glucosidase inhibitors